openPR Logo
Press release

Triple-Negative Breast Cancer Treatment Market Set to Witness an Uptick During 2017 – 2025

08-02-2017 03:05 PM CET | Health & Medicine

Press release from: Persistence Market Research

Triple-Negative Breast Cancer Treatment Market Set to Witness

Breast cancer is cancer that effects the breast tissue. Breast cancer is the most commonly diagnosed cancer among American women, besides skin cancer. Currently, to treat breast cancer various drugs like hormonal treatment, HER2 receptor-based drugs are available in the market. However, these drugs will not act against on triple-negative breast cancers this is mainly due to absence of receptors in triple-negative breast cancer conditions. Usually, in breast cancer cells they have receptors on their surface for HER2 protein, estrogen and progesterone hormones. If the breast cancer test shows positive for these receptors, it signifies breast cancer cells have receptors for estrogen, progesterone, and HER2 protein. These receptors are responsible for the growth of cancer. However, these receptors are absent in triple-negative breast cancer conditions. Hence, triple breast cancer can't be treat with targeted therapies such as aromatase inhibitors and hormonal based therapies. Till date, there were no specific drugs in the market that can treat triple-negative breast cancer - leaving patients with fewer options by treating with surgery, radiotherapy and chemotherapy. In most of the cases, after performing surgery chemotherapy treatment is given - adjuvant chemotherapy. In some cases, chemotherapy is given before surgery - neoadjuvant chemotherapy. In this treatment procedure, it helps in reduction of tumor size of breast cancer. About 10-20% of breast cancers cases are triple-negative breast cancers. Unmet need of triple-negative breast cancer is lack of proper interventions and treatment protocols. Few companies are trying to develop molecules that can treat triple-negative breast cancer conditions. For instance, Eribulin mesylate (Halaven®), developed by Eisai, completed clinical trials Phase 3 studies to treat triple-negative breast cancer conditions. In February 2016, Sacituzumab Govitecan (IMMU-132) got U.S. FDA breakthrough therapy designation for its treatment of triple-negative breast cancer conditions. IMMU-132 is an antibody-drug conjugate that acts by binding to protein Trop2 that overexpresses in triple breast cancer. Various other molecules are currently undergoing clinical trials to treat triple negative breast cancer.

Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/14305

According to the research article published in Journal of the Moffitt Cancer Center, around 1 million breast cancers are diagnosed globally among them 1.7% of cancer cases are triple-negative cancers. Triple-negative breast cancers are more aggressive and fewer survival rates when compared with breast cancer. Increase in incidence of breast cancers globally, and higher mortality rates related to breast cancers in developing countries are projected to driving the growth of this market during the forecast period. Lack of treatment regimens and proper drugs to treat this condition are hindering growth of this market.

Therapeutic area of triple-negative breast cancer treatment market was segmented into alkylating agents, natural products, antimetabolites and microtubule stabilizing agents. Alkylating agents is further segmented into Platinum coordination complexes. Natural products category is segmented into Plant products and Microorganism products.

Based on the route of administration, the triple-negative breast cancer treatment market was segmented into oral and parenteral. Parenteral route occupies the major market share followed by the oral route.

On the basis of the distribution channel, triple-negative breast cancer treatment market is segmented into hospital and retail pharmacies Hospital pharmacies accounts largest market share due to availability of these drugs in hospitals to treat breast cancer

Based on the geographic region, triple-negative breast cancer treatment market is segmented into five key regions: North America, Latin America, Europe, Asia-Pacific and the Middle East & Africa. North America occupies the major market share due to high research activities on triple-negative breast cancer, buying power of patients are the major factors boosting the growth of this market during the forecast period. Asia Pacific region is expected to grow with highest CAGR over the forecast period due to high incidence and mortality rates of breast cancer condition in this region.

Some of the players in triple-negative breast cancer treatment market include Celgene, Roche, Immunomedics GmbH, Merck & Co., Inc., F. Hoffmann-La Roche Ltd and Eisai Co., Ltd.

To view complete report @http://www.persistencemarketresearch.com/market-research/triple-negative-breast-cancer-treatment-market.asp

About Us 
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
 PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

Contact
Persistence Market Research Pvt. Ltd
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
media@persistencemarketresearch.com
Web:www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Triple-Negative Breast Cancer Treatment Market Set to Witness an Uptick During 2017 – 2025 here

News-ID: 652790 • Views: 199

More Releases from Persistence Market Research

HVAC Packaged Units Market Progresses for Huge Profits during 2030
Rapidly growing demand from commercial and residential construction projects and prominence of automation in HVAC systems are some of the vital driving factors for the HVAC packaged units market. Substantial increase in implementation of packaged units, owing to minimal space requirement and efficient operations, is expected to ascend demand for HVAC packaged units over the coming years. To remain 'ahead' of your competitors, request for a sample @ https://www.persistencemarketresearch.com/samples/23671 The global HVAC packaged
North America Antifreeze And Coolants Market to Witness Exponential Growth by 20 …
Ongoing developments in the automotive sector have led to significant product innovations in the antifreeze and coolants industry. Rising vehicle numbers, emerging economies, and increased per capita income are leading to surging demand for advanced versions of antifreeze and coolants on a large scale. This will heighten the procurement rate of antifreeze/coolants during the forecast period, thereby aiding growth of the North America antifreeze and coolants market. To remain 'ahead' of
Ventilation Equipment Market to Record Sturdy Growth by 2030
Rapidly growing population, rising urbanization, increase in spending, and urge to invest in proper ventilation at homes, workplaces and manufacturing units are vital driving factors for the growth of the ventilation equipment market. To remain 'ahead' of your competitors, request for a sample @ https://www.persistencemarketresearch.com/samples/16330 Ventilation Equipment Market The industrial manufacturing sector has witnessed significant growth in recent years, and this growth is estimated to persist over the coming years, subsequently ascending the demand
Industrial Racking System Market to See Incredible Growth during 2030
The need for flexible material storing and stacking architectures with new safety features and resource efficiency for all industries is a vital driving factor for the industrial racking system market. The industrial manufacturing sector has witnessed significant growth in recent years, and this growth is estimated to persist over the coming years. Rising e-Commerce sector is also a vital market driver. As such, the global industrial racking system market is

All 5 Releases


More Releases for Breast

Breast Reduction Bangalore
The Pros and Cons of a Breast Reduction: All of these symptoms can be a telltale sign your breasts are too heavy for your frame: Pressure on the shoulders caused by bra straps supporting too much weight. Severe back and neck pain. Numbness in your hands and fingers. Headaches. Shortness of breath. Breast reduction is a surgical procedure that reduces the size and weight of the breasts. It has proven to be a popular solution to alleviate
Soaring Instances of Breast Cancer to Propel Breast Imaging Market
"The Report Breast Imaging Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 - MarketResearchReports.biz" An intelligence report on the global breast imaging market has been added to the burgeoning portfolio of MarketResearchReports.biz. Titled, “Breast Imaging Market (Mammography, Breast MRI, Breast Ultrasound, Tomosynthesis, Nuclear Imaging and Others [Breast Thermography & Bioelectric Imaging]) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” the
What Is A Combined Breast Augmentation With Breast Lift?
Combined Breast Augmentation And Lift: How Is It Performed? Surrounding the areola one incisions is made to remove the excess skin and another vertically incisions is made to the base of breasts starting from low part of the areola. Sometimes the scar is referred to as the “Lollipop scar”. Implants are placed through the incisions made and positioned carefully by the surgeon under the pectoral chest muscle, where the implants can
Global Breast Pumps Market
The Global Breast Pumps Market was valued at US$ 606.6 million in 2015 and is projected to expand at a CAGR of 4.8% during 2016–2024,according to a new report published by Coherent Market Insights. Rapidly growing population and improving insurance scenario is propelling demand for breast pumps worldwide. Demand for electronic breast pumps is gaining high traction in terms mainly due to adjustable suction level aiding ease of use. A more
Liposuction Breast Reduction
Portsmouth, NH - Liposuction Breast Reduction, also known as Scarless Breast Reduction continues to gain in popularity over the traditional method of breast reduction for the relief of back, neck and shoulder pain. More and more patients are dissatisfied with the older method and are requesting the less invasive method over the twelve inches of scarring per breast. Plastic Surgeons are responding to their patients and are performing more and
Breast Cancer-Breast Conservation Is A Possibility
New Delhi - April 27, 2011: The incidence of breast cancer is rapidly increasing in India and has overtaken cancer of cervix in Indian women in metropolitan cities. One in 22 Indian women are likely to develop breast cancer during their lifetime. Breast cancer is a disease of old age with the peak incidence in the fifth and sixth decades - but in India the disease is seen a decade